Masitinib in Patients With Mild Alzheimer's Disease

NCT05564169 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Placebo
DRUG: Masitinib (4.5)
DRUG: Standard of care

Sponsor

AB Science